InnoCare Pharma (SHA:688428, HKG:9969) posted a first-quarter net profit attributable to shareholders of 18.0 million yuan, compared with a loss of 142.4 million yuan a year ago.
Earnings per share stood at 0.01 yuan, versus a loss per share of 0.08 yuan, according to a Tuesday filing with the Shanghai bourse.
The biopharmaceutical company's revenue jumped 130% year over year to 381.3 million yuan from 165.8 million yuan.
Shares of InnoCare Pharma were down 3% on the Shanghai bourse and 4% on the Hong Kong bourse in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.